Key Market Segments:
By Product Type
-
Instruments
-
Reagents
-
Consumables
By Technology
-
Immunoassay
-
Hematology
-
Clinical Chemistry
-
Molecular Diagnostics
-
Coagulation
-
Microbiology
-
Others
By Test Location
-
Point of Care
-
Home-care
-
Others
By Application
-
Infectious Diseases
-
Diabetes
-
Oncology
-
Cardiology
-
Nephrology
-
Autoimmune Diseases
-
Drug Testing
-
Other applications
By End-user
-
Hospitals
-
Laboratory
-
Home Care
-
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
-
US
-
Canada
-
Mexico
Europe
-
Eastern Europe
-
Poland
-
Romania
-
Hungary
-
Turkey
-
Rest of Eastern Europe
-
-
Western Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Netherlands
-
Switzerland
-
Austria
-
Rest of Western Europe
-
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Vietnam
-
Singapore
-
Australia
-
Rest of Asia Pacific
Middle East & Africa
Middle East
-
UAE
-
Egypt
-
Saudi Arabia
-
Qatar
-
Rest of the Middle East
Africa
-
Nigeria
-
South Africa
-
Rest of Africa
Latin America
-
Brazil
-
Argentina
-
Colombia
-
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Product Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Product Matrix which gives a detailed comparison of the product portfolio of each company
-
Geographic Analysis
-
Additional countries in any of the regions
-
Company Information
-
Detailed analysis and profiling of additional market players (Up to five)
Frequently Asked Questions
North America is the dominant region with a 42.2% share in the IVD (In Vitro Diagnostics) market.
The high costs of instruments are the restraints on the IVD (In Vitro Diagnostics) market.
The rising aging population fuels the demand for innovative diagnostic solutions.
The projected market value of the IVD (In Vitro Diagnostics) market is estimated at USD 83.04 billion in 2023 and is expected to reach USD 126.6 billion by 2032.
The estimated compound annual growth rate is 4.8% during the forecast period for the IVD (In Vitro Diagnostics) market.